CAS 4701-54-6
:(5aR,5bS,8S,9R,11aS,11bR,12R,13aS)-9,12-dihydroxy-5a,8,11a,14-tetramethyl-2-(4-methylpent-3-en-1-yl)-5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-tetradecahydro-1,5-methanophenanthro[1,2-c]oxepin-3(5H)-one
Description:
The chemical substance with the name "(5aR,5bS,8S,9R,11aS,11bR,12R,13aS)-9,12-dihydroxy-5a,8,11a,14-tetramethyl-2-(4-methylpent-3-en-1-yl)-5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-tetradecahydro-1,5-methanophenanthro[1,2-c]oxepin-3(5H)-one" and CAS number "4701-54-6" is a complex organic compound characterized by its intricate stereochemistry and multiple functional groups. It features a tetradecahydro structure, indicating a saturated hydrocarbon framework with numerous chiral centers, which contributes to its potential biological activity. The presence of hydroxyl groups suggests it may exhibit polar characteristics, enhancing its solubility in polar solvents. The compound's structure includes a methanophenanthro-oxepin core, which is indicative of potential pharmacological properties, possibly related to natural products or synthetic analogs. Its specific stereochemistry may influence its interactions with biological targets, making it of interest in medicinal chemistry. Overall, this compound exemplifies the complexity and diversity found in organic molecules, particularly those with potential therapeutic applications.
Formula:C29H44O4
InChI:InChI=1/C29H44O4/c1-15(2)8-7-9-18-24-17(4)26(33-27(18)32)29(6)20-11-10-19-16(3)22(30)12-13-28(19,5)25(20)23(31)14-21(24)29/h8,16-17,19-23,25-26,30-31H,7,9-14H2,1-6H3/t16-,17?,19?,20-,21-,22+,23+,25-,26?,28-,29+/m0/s1
InChI key:WESBIDUQKXCXGS-XEVGSQSQSA-N
SMILES:C[C@@H]1[C@@H](CC[C@]2(C1CC[C@]3([C@H]2[C@@H](C[C@@H]4[C@@]3(C[C@H]5C4=C(C(=O)O5)CCC=C(C)C)C)O)C)C)O
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
FUSIDIC ACID IMPURITY MIXTURE CRS
CAS:FUSIDIC ACID IMPURITY MIXTURE CRSColor and Shape:Added Modified(2aS,3S,4R,6aS,6bS,7R,8aR,11aS,12aS,12bS)-4,7-Dihydroxy-3,6a,12a,12b-tetramethyl-9-(4-methylpent-3-en-1-yl)-2a,3,4,5,6,6a,6b,7,8,8a,11a,12,12a,12b-tetradecahydro-1H-naphtho[2',1':4,5]indeno[2,1-b]fura
CAS:(2aS,3S,4R,6aS,6bS,7R,8aR,11aS,12aS,12bS)-4,7-Dihydroxy-3,6a,12a,12b-tetramethyl-9-(4-methylpent-3-en-1-yl)-2a,3,4,5,6,6a,6b,7,8,8a,11a,12,12a,12b-tetradecahydro-1H-naphtho[2',1':4,5]indeno[2,1-b]furaFormula:C29H44O4Purity:95%Molecular weight:456.66Sodium Fusidate EP Impurity K
CAS:Formula:C29H44O4Color and Shape:White To Off-White SolidMolecular weight:456.6716-Deacetylfusidic Acid γ-Lactone
CAS:Controlled ProductApplications 16-Deacetylfusidic Acid γ-Lactone is a metabolite of the drug Fusidic Acid (F865500). Fusidic acid is a bacteriostatic antibiotic. Fusidic Acid suppresses nitric oxide lysis of pancreatic islet cells. Inhibits protein synthesis in prokaryotes by inhibiting the ribosome-dependent activity of G factor and translocation of peptidyl-tRNA.
References Collignon, P., et al.: Int. J. Antimicrob. Agents, 12, S45 (1999); Di Marco, R., et al.: J. Autoimmun., 13, 187 (1999); Price, C.T., et al.: J. Antimicrob., Chemother., 44, 57 (1999)Formula:C29H44O4Color and Shape:NeatMolecular weight:456.657316-O-Deacetyl fusidic acid lactone
CAS:16-O-Deacetyl fusidic acid lactone (16-Deacetylfusidic acid γ-lactone) (FA-9) is a lactone derivative of fusidic acid with antibacterial properties. It is effective against Gram-positive bacteria but has no inhibitory effect on Gram-negative bacteria.Formula:C29H44O4Molecular weight:456.66







